We are live on ! Find out more
Daniel Devine & Co

Daniel Devine & Co Portfolio holdings

AUM $125M Turnover 9.62%
1-Year Est. Return 14.12%
This Fund
S&P 500
This Quarter Est. Return
-8.6%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.27M
Cap. Flow
+$9.6M
Cap. Flow %
6.78%
Top 10 Hldgs %
57.32%
Holding
65
New
3
Increased
17
Reduced
3
Closed
1
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.6 years

Top Sells

Rank Stock Value
1
AMLP icon
Alerian MLP ETF
AMLP
+$211K
2
AMJ icon
JPMorgan Alerian MLP Index ETN
AMJ
+$180K
3
MCD icon
McDonald's
MCD
+$100K
4
ABT icon
Abbott
ABT
+$23.6K

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.36%
2 Healthcare 9.91%
3 Industrials 9.75%
4 Technology 7.44%
5 Financials 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VWO icon
51
Vanguard FTSE Emerging Markets ETF
VWO
$112B
$434K 0.31%
13,125
– –
2014 Q4
3 quarters
PAA icon
52
Plains All American Pipeline
PAA
$17B
$355K 0.25%
11,700
+500
+4% +$18.3K
2014 Q4
3 quarters
BPL
53
DELISTED
Buckeye Partners
BPL
$350K 0.25%
5,900
– –
2014 Q4
3 quarters
DVY icon
54
iShares Select Dividend ETF
DVY
$22.8B
$339K 0.24%
4,660
– –
2014 Q4
3 quarters
AMJ icon
55
DELISTED
JPMorgan Alerian MLP Index ETN
AMJ
$334K 0.24%
11,000
-5,000
-31% -$180K
2014 Q4
3 quarters
IOO icon
56
iShares Global 100 ETF
IOO
$8.54B
$327K 0.23%
+9,450
New +$347K
2015 Q3
0 quarters
ETP
57
DELISTED
Energy Transfer Partners
ETP
$267K 0.19%
6,500
– –
2014 Q4
3 quarters
EWT icon
58
iShares MSCI Taiwan ETF
EWT
$8.17B
$263K 0.19%
10,000
– –
2014 Q4
3 quarters
AZN icon
59
AstraZeneca
AZN
$272B
$235K 0.17%
3,700
– –
2015 Q1
2 quarters
AMD icon
60
Advanced Micro Devices
AMD
$815B
$53K 0.04%
31,000
– –
2015 Q1
2 quarters
AMLP icon
61
Alerian MLP ETF
AMLP
$12B
– –
-2,716
Closed -$211K –

Similar funds

Daniel Devine & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Daniel Devine & Co held 65 positions worth $141M, down 2.9% from $146M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Daniel Devine & Co deployed $9.6M of net new capital in Q3 2015, opening 3 new positions and adding to 17 existing holdings. Its largest new stake was iShares Biotechnology ETF: 35,910 shares worth $3.63M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 49% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was JPMorgan Alerian MLP Index ETN, an estimated $180K trimmed.

  • Daniel Devine & Co's largest Q3 2015 buy was iShares Biotechnology ETF: 35,910 shares worth $3.63M.
  • Daniel Devine & Co added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $2.37M increase.
  • Daniel Devine & Co's biggest Q3 2015 reduction was JPMorgan Alerian MLP Index ETN, cutting an estimated $180K.
  • Daniel Devine & Co fully exited Alerian MLP ETF in Q3 2015, selling an estimated $211K.
  • Daniel Devine & Co's ten largest holdings make up 57% of its $141M portfolio in Q3 2015.
  • Daniel Devine & Co opened 3 new positions and closed 1 in Q3 2015.
  • Daniel Devine & Co's portfolio value fell 2.9% quarter-over-quarter to $141M.

Based on Daniel Devine & Co's 13F filing for Q3 2015, filed 15 Oct 2015.